Skip to content

Male Pattern Baldness - Androgenetic Alopecia

NO LONGER ACCEPTING APPLICATIONS
Published on:
May 5, 2025
Sign-up Expiration:
Updated:
Topics:
Locations:

This research study will compare VDPHL01 with placebo (no active ingredient) to learn about the safety and how VDPHL01 works on androgenetic alopecia (AGA). AGA is a genetic disorder caused by an excessive (too much) hair follicle response to androgens resulting in hear loss.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED